Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Phys Rev Lett ; 132(16): 166702, 2024 Apr 19.
Article in English | MEDLINE | ID: mdl-38701457

ABSTRACT

The magnetic ground state of single crystalline RuO_{2} was investigated by the muon spin rotation and relaxation (µSR) experiment. The spin precession signal due to the spontaneous internal magnetic field B_{loc}, which is expected in the magnetically ordered phase, was not observed in the temperature range 5-400 K. Muon sites were evaluated by first-principles calculations using dilute hydrogen simulating muon as pseudohydrogen, and B_{loc} was simulated for the antiferromagnetic structures with a Ru magnetic moment |m_{Ru}|≈0.05µ_{B} suggested from diffraction experiments. As a result, the possibility was ruled out that muons are localized at sites where B_{loc} accidentally cancels. Conversely, assuming that the slow relaxation observed in µSR spectra was part of the precession signal, the upper limit for the magnitude of |m_{Ru}| was estimated to be 4.8(2)×10^{-4}µ_{B}, which is significantly less than 0.05µ_{B}. These results indicate that the antiferromagnetic order, as reported, is unlikely to exist in the bulk crystal.

2.
Opt Express ; 29(17): 27137-27148, 2021 Aug 16.
Article in English | MEDLINE | ID: mdl-34615135

ABSTRACT

Precise spectroscopy of the hyperfine level system of 167Er-doped Y2SiO5 was achieved in the frequency domain. By using an optical frequency comb to stabilize the light source frequency to an accuracy on the order of hertz on a long-term scale, Allan deviation < 10 Hz was achieved for an integration time of 180 s. As a result, spectral hole-burning experiments yielded a more accurate hole spectrum with a narrow homogeneous linewidth. The method opens the way to the straightforward exploration of relaxation mechanisms in the frequency domain by simple steady-state measurements.

3.
Phys Rev Lett ; 103(2): 027002, 2009 Jul 10.
Article in English | MEDLINE | ID: mdl-19659235

ABSTRACT

The presence of a macroscopic phase separation between the superconducting and magnetic phases in CaFe1-xCoxAsF is demonstrated by muon spin rotation measurements conducted across their phase boundaries (x=0.05-0.15). The magnetic phase tends to retain the high transition temperature (Tm>Tc), while Co doping induces strong randomness. The volumetric fraction of the superconducting phase is nearly proportional to the Co content x with a constant superfluid density. These observations suggest the formation of superconducting "islands" (or domains) associated with Co ions in the Fe2As2 layers, indicating a very short coherence length.

4.
Phys Rev Lett ; 100(9): 097002, 2008 Mar 07.
Article in English | MEDLINE | ID: mdl-18352744

ABSTRACT

A complex structure of the superconducting order parameter in Ln2C3 (Ln=La,Y) is demonstrated by muon spin relaxation measurements in their mixed state. The muon depolarization rate sigma v(T)] exhibits a characteristic temperature dependence that can be perfectly described by a phenomenological double-gap model for nodeless superconductivity. While the magnitude of two gaps is similar between La2C3 and Y2C3, a significant difference in the interband coupling between those two cases is clearly observed in the behavior of sigma v(T).

5.
Surg Endosc ; 12(12): 1419-23, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9822470

ABSTRACT

We treated a complete obstruction of the left mainstem bronchus due to nonresectable recurrent esophageal carcinoma with a combination of laser therapy, radiation therapy, and the placement of an expandable metallic stent. The patient survived 1 year after the first therapy, with good quality of life. We conclude that a combination of laser ablation, radiotherapy, and stent placement can improve survival and quality of life for the patients with complete malignant bronchial obstruction.


Subject(s)
Airway Obstruction/therapy , Esophageal Neoplasms/complications , Esophageal Neoplasms/therapy , Palliative Care/methods , Stents , Aged , Aged, 80 and over , Airway Obstruction/etiology , Bronchoscopy , Combined Modality Therapy , Esophageal Neoplasms/pathology , Esophagectomy , Fatal Outcome , Humans , Laser Therapy/methods , Male , Neoplasm Recurrence, Local/complications , Neoplasm Recurrence, Local/therapy , Radiotherapy/methods , Treatment Outcome
6.
J Womens Health ; 7(5): 575-82, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9650158

ABSTRACT

This study was designed to determine if there is a difference in autonomic regulation induced by posture change between postmenopausal and young women. To evaluate autonomic nervous system function, spectral analysis of heart rate variability (HRV) was done in postmenopausal women (n = 13, 46-59 years of age), age-matched men (n = 8, 45-55 years of age), and young women (n = 10, 20-37 years of age) for 3-min periods of controlled frequency breathing (15 breaths/min) in supine followed by sitting positions. In the supine position, the R-R interval variation in older persons decreased significantly compared with that during the follicular phase in young women. Furthermore, the high-frequency (HF) components of HRV, which reflect only parasympathetic activity, were lower in older subjects than in young women. Following a change of position from supine to sitting, the HF component did not change significantly in the postmenopausal women or the men, but the low/high frequency (LF/HF) component ratio, which reflects the balance of autonomic nerve activities, increased significantly in the men. These results suggest that cardiac parasympathetic tone may be reduced in older persons in comparison with young women. Furthermore, arterial baroreflex control of parasympathetic nerve activity caused by posture changes is impaired in the postmenopausal women and aged-matched men. The baroreflex control of the sympathetic component is maintained in the men but not in the postmenopausal women. These differences might result in part from changes in the level of female hormones.


Subject(s)
Autonomic Nervous System/physiology , Baroreflex/physiology , Postmenopause/physiology , Posture/physiology , Adult , Age Factors , Electrocardiography , Female , Heart Rate/physiology , Humans , Male , Middle Aged , Premenopause/physiology , Supine Position/physiology
7.
Laryngoscope ; 108(7): 1071-6, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9665259

ABSTRACT

OBJECTIVES: To clarify mastoid pneumatization in children with congenital cholesteatoma and compare their clinical characteristics. STUDY DESIGN: The mastoid pneumatization of 34 children with congenital middle ear cholesteatoma, of 34 age-matched children with unilateral acquired cholesteatoma, and of 17 age-matched control children without middle ear diseases was studied. METHODS: The sizes of the mastoid cells were measured from 1.5-mm sliced semiaxial sections of a temporal bone computed tomography scan. The sum of the two areas from the two images, one showing the lateral semicircular canal and the other, 3 mm below this, was defined as the area of the pneumatized mastoid cells. RESULTS: The mastoid cells in ears of children with congenital cholesteatoma were poorly pneumatized compared with those of control children without middle ear diseases, but were better pneumatized compared with those of children with acquired cholesteatoma. In children with congenital cholesteatoma, the degree of pneumatization in the cholesteatoma side was significantly poorer than that in the opposite side. A well-pneumatized mastoid was seen in ears with no episode of otitis media, in ears with the open-type cholesteatoma, and in ears with ossicular anomalies. CONCLUSIONS: The presence of cholesteatoma matrix accelerates the inflammatory response when middle ear infections occur, and this probably leads to the suppression of mastoid pneumatization. The authors also propose the hypothesis that cholesteatoma in most congenital cases is the open type, and that middle ear inflammation may contribute to the formation of cystic and closed-type cholesteatoma.


Subject(s)
Cholesteatoma, Middle Ear/congenital , Cholesteatoma, Middle Ear/etiology , Mastoid/diagnostic imaging , Mastoid/pathology , Adolescent , Case-Control Studies , Child , Child, Preschool , Cholesteatoma, Middle Ear/classification , Cholesteatoma, Middle Ear/surgery , Female , Humans , Image Processing, Computer-Assisted , Inflammation , Male , Tomography, X-Ray Computed
8.
Gan To Kagaku Ryoho ; 25(6): 887-900, 1998 May.
Article in Japanese | MEDLINE | ID: mdl-9617328

ABSTRACT

In Japan, long-term oral therapy with tegafur in combination with immunopotentiators is commonly used as adjuvant therapy after curative resection of gastric or colorectal can for gastric and colorectal cancer. When the outcome was analyzed in terms of the relative performance (R.P.) and the individual dose intensity (I.D.I.) of OK-432, gastric cancer patients with a R.P. of 0.5 or higher tended to have a better survival curve. There were no marked differences in lymphocytes subsets, except that the Leu 7 level at 3 months after gastric cancer resection was significantly higher (p < 0.05) in group B than in group A. Thus, no inhibition of the anticancer effect of UFT was noted during long term combination therapy with UFT and an immunopotentiator as postoperative adjuvant therapy for patients who underwent curative resection of gastric or colorectal cancer. The results suggest that UFT combined with long-term OK-432 maintenance therapy may contribute to improve survival rates in gastric cancer patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Colonic Neoplasms/therapy , Picibanil/administration & dosage , Rectal Neoplasms/therapy , Stomach Neoplasms/therapy , Tegafur/therapeutic use , Uracil/therapeutic use , Adjuvants, Immunologic/administration & dosage , Chemotherapy, Adjuvant , Colonic Neoplasms/mortality , Colonic Neoplasms/surgery , Disease-Free Survival , Drug Combinations , Humans , Middle Aged , Rectal Neoplasms/mortality , Rectal Neoplasms/surgery , Stomach Neoplasms/mortality , Stomach Neoplasms/surgery , Survival Rate , Tegafur/administration & dosage , Uracil/administration & dosage
9.
Curr Genet ; 33(1): 60-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9472081

ABSTRACT

Aspergillus nidulans is a non-pathogenic fungus with well-developed genetics which provides an excellent model system for studying different aspects of drug resistance in filamentous fungi. As a preliminary step to characterizing genes that confer pleiotropic drug resistance in Aspergillus, we isolated cycloheximide-sensitive mutants of A. nidulans, which is normally resistant to this drug. The rationale for this approach is to identify genes whose products are important for drug resistance by analysing mutations that alter the resistance/sensitivity status of the cell. Fifteen cycloheximide-sensitive (named scy for sensitive to cycloheximide) mutants of A. nidulans were isolated and genetically characterised. Each scy mutant was crossed with the wild-type strain and five of the crosses gave 50% cycloheximide-sensitive progeny suggesting that they carry a single mutation required for cycloheximide sensitivity. We examined ten scy mutants for resistance/sensitivity to other drugs or stress agents with different and/or the same mechanism of action. Six of these mutants exhibited other altered resistance/sensitivity phenotypes which were linked to the cycloheximide sensitivity. These six mutants were analyzed by pairwise crosses and found to represent six linkage groups, named scyA-F. One of the mutants showed fragmentation of its vacuolar system and, in addition, its growth was osmotic, low-pH, and oxidative-stress sensitive.


Subject(s)
Aspergillus nidulans/genetics , Aspergillus nidulans/isolation & purification , Cycloheximide/pharmacology , Mutation , Aspergillus nidulans/drug effects , Aspergillus nidulans/ultrastructure , Drug Resistance, Microbial/genetics , Microbial Sensitivity Tests , Mutation/drug effects , Phenotype , Vacuoles/genetics
11.
Am J Gastroenterol ; 91(10): 2200-2, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8855748

ABSTRACT

In this report, we describe a case with triple tiny cancers of the stomach developing adjacent to each other and resected endoscopically in a single mucosal piece. The three cancers differed from each other histologically. The surrounding mucosa was atrophic pyloric gland mucosa with moderate to severe intestinal metaplasia. Both histological and serological examinations were negative for Helicobacter pylori. Each of the three cancer lesions was positive for mutant p53 product immunohistochemically. None of the cancers were positive for Epstein-Barr virus sequence in an in situ hybridization analysis. These lesions suggest that certain local conditions in the gastric mucosa can result in carcinogenesis of different histological types of gastric cancers.


Subject(s)
Adenocarcinoma, Papillary/pathology , Adenocarcinoma, Papillary/surgery , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/surgery , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , Adenocarcinoma/microbiology , Adenocarcinoma, Papillary/microbiology , Aged , Endoscopy , Genes, p53 , Humans , Lymphoma, T-Cell, Cutaneous/pathology , Male , Neoplasms, Multiple Primary/microbiology , Risk Factors , Stomach Neoplasms/microbiology
12.
Hepatogastroenterology ; 43(10): 995-9, 1996.
Article in English | MEDLINE | ID: mdl-8884327

ABSTRACT

A patient with primary gastric carcinoma showing a high level of serum a-fetoprotein (AFP) (368 ng/ml) is described. Subtotal gastrectomy was performed, and a month after surgery the level of serum AFP fell rapidly to within normal limits. Histologically, two types of cells coexisted in the tumor: medullary-type cells resembling trabecular-type hepatocellular carcinoma, and moderately differentiated adenocarcinoma cells. The cells of the former type were arranged mostly in a trabecular pattern with bile granules, but also showed a scirrhous pattern in a restricted area. Immunohistochemistry demonstrated that both types of tumor cells stained positively for AFP. This tumor, which should be classified as a hepatoid adenocarcinoma of the stomach, is of interest because of its rarity, bile secretion (indicating marked differentiation toward a hepatocyte form), and two cellular arrangements-trabecular and scirrhous.


Subject(s)
Adenocarcinoma/pathology , Carcinoma, Hepatocellular/pathology , Stomach Neoplasms/pathology , Stomach/pathology , Adenocarcinoma/diagnosis , Adenocarcinoma/surgery , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/surgery , Gastrectomy , Humans , Male , Middle Aged , Stomach Neoplasms/diagnosis , Stomach Neoplasms/surgery , alpha-Fetoproteins/analysis
13.
Hepatogastroenterology ; 43(10): 1000-5, 1996.
Article in English | MEDLINE | ID: mdl-8884328

ABSTRACT

A patient with a primary gastric carcinoma complicated with a tumor thrombus in the portal vein is described. Pancreatoduodenectomy with tube pancreatostomy was performed. The location and size of tumor thrombi in the portal vein could be determined accurately by intraoperative ultrasonography and removed with the wall of the portal vein and superior mesenteric vein. There was no evidence of recurrence one year after the operation. Tumor thrombus in the portal vein in gastric cancer is rarely reported and has a poor prognosis. If there is no associated liver metastasis, aggressive surgical approach followed by appropriate chemotherapy may prolong the life of the patient.


Subject(s)
Adenocarcinoma/pathology , Neoplastic Cells, Circulating , Portal Vein , Stomach Neoplasms/pathology , Adenocarcinoma/surgery , Aged , Humans , Male , Portal Vein/pathology , Prognosis , Stomach/pathology , Stomach Neoplasms/surgery
14.
Gan To Kagaku Ryoho ; 22(8): 994-1000, 1995 Jul.
Article in Japanese | MEDLINE | ID: mdl-7611769

ABSTRACT

Sequential MTX/5-FU therapy was performed on 64 patients with unresectable or recurrent gastric cancer. The therapy was most effective in patients with poorly differentiated type gastric cancer. We adopted the intermediate (MTX: 100mg/m2, 5-FU: 800mg/m2) and low (MTX: 30mg/m2, 5-FU: 600 mg/m2) dose regimens. The latter was performed at the outpatient clinic every 2 weeks. This therapy was used for patients with Borrmann type 4 gastric cancer or advanced gastric cancer of poorly differentiated type as postoperative adjuvant chemotherapy. The response rate was 25% in 44 evaluable patients, and 33% in patients with poorly differentiated type cancer. As an adverse effect, leukopenia (grade 3, 4) was observed in 4 patients (9%). The 5-year cumulative survival rate of the sequential MTX/5-FU therapy group (52.6%) was much better than the conventional adjuvant chemotherapy group (32.1%) in patients who underwent curative resection with Borrmann type 4 gastric cancer. One patient survived more than 900 days after non-curative resection with peritoneal dissemination (P 3) after low dose therapy of sequential MTX/5-FU. For the patients who did not respond to the MTX/5-FU therapy, MTX/CDDP/LV/5-FU therapy was adopted. This protocol consisted of MTX (30 mg/m2 iv; day 1), CDDP (60 mg/m2 div; day 2 and day 9), Leucovorin (30 mg iv; day 2-9) and 5-FU (250 mg/m2 div; day 2-9). We also performed MTX/CDDP/LV/5-FU therapy for the treatment of differentiated type gastric cancer.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Drug Administration Schedule , Fluorouracil/administration & dosage , Humans , Methotrexate/administration & dosage , Neoplasm Recurrence, Local/drug therapy , Prognosis , Stomach Neoplasms/mortality , Survival Rate
15.
Ann Surg ; 221(2): 165-70, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7531967

ABSTRACT

OBJECTIVE: The authors used prolamine (Ethibloc, Ethicon GmBH, Norderstedt, Germany) for segmental obstruction of the pancreatic duct to prevent pancreatic fistula development after distal pancreatectomy combined with total gastrectomy for gastric malignancies. SUMMARY BACKGROUND DATA: Although the initial clinical application of prolamine was pancreatic duct obstruction for patients with pancreatitis and undergoing pancreatic transplantation and pancreaticoduodenectomy for pancreatic cancer, there are no reports on prevention of pancreatic fistula formation after distal pancreatectomy. METHODS: Prolamine (0.2 mL) was injected into the distal segment of the main duct in the remaining pancreata of 51 patients. Small pancreatic ducts on the cut surface, from which prolamine extravasates, were closed by ligation, the main duct was ligated doubly, and the transected pancreatic margin was closed 15 minutes after phenylpropanolamine hydrochloride injection. RESULTS: No patient developed a pancreatic fistula or the complication of arterial bleeding due to prolonged infection. CONCLUSION: Segmental obstruction of the pancreatic duct with prolamine is useful for preventing pancreatic fistula development after distal pancreatectomy.


Subject(s)
Diatrizoate , Fatty Acids , Pancreatectomy , Pancreatic Ducts , Pancreatic Fistula/prevention & control , Postoperative Complications/prevention & control , Propylene Glycols , Sclerosing Solutions , Zein , Amylases/blood , Drug Combinations , Gastrectomy , Gels , Humans , Splenectomy , Stomach Neoplasms/surgery
16.
Anticancer Res ; 14(3B): 1277-9, 1994.
Article in English | MEDLINE | ID: mdl-8067696

ABSTRACT

The therapeutic efficacy and toxicity of sequential methotrexate and 5-fluorouracil in 64 inoperable gastric cancer patients are reported. An intermediate-dose treatment was given to 48 patients, and a low-dose treatment to 16 patients. In the intermediate-dose treatment, leukopenia was observed in 11 patients, nausea and vomiting in six patients and diarrhea and stomatitis in two patients each. In the low-dose treatment, no patient developed toxic symptoms of grade 3 or 4. All 9 responders had adenocarcinoma of the poorly differentiated type and the response rate in patients who belonged to this type was 32.1%.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Female , Fluorouracil/administration & dosage , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Stomach Neoplasms/enzymology , Thymidine Kinase/metabolism
17.
J Exp Zool ; 267(3): 344-9, 1993 Nov 01.
Article in English | MEDLINE | ID: mdl-8228869

ABSTRACT

To examine the factors affecting the survival of refrigerated embryos, rabbit and mouse morulae were stored at 0 degrees C in modified phosphate-buffered saline (PB1) or in PB1 containing 0.75 M sucrose. Survival was defined as the ability to develop into an expanded blastocyst in culture. The data was analyzed with special reference to the presence of a mucin coat around the embryos. When rabbit morulae were stored in isotonic PB1 for 2, 4, 6, and 8 days, survival rates were 98%, 88%, 85%, and 50%, respectively. However, if the mucin coat had been removed before storage, the rates were lower (95%, 75%, 36%, and 3%, respectively). Sucrose impaired the survival of rabbit morulae irrespective of the presence of the mucin coat. Only 11% of mouse morulae survived 2 days of storage in PB1 medium, but if the medium contained sucrose, survival rates after storage for 2, 3, 4, and 5 days were higher (83%, 55%, 31%, and 7%, respectively). To provide them with a mucin coat around the zona pellucida, mouse embryos were incubated in a rabbit oviduct. Survival rates of these embryos after storage in the presence of sucrose did not decrease over 4 days of refrigeration (98-92%), and the rates after storage for 5, 6, and 7 days were 65%, 40%, and 30%, respectively; embryos that had been stored for 5 days were transferred to recipient mice, and live young were born. Agar embedding of mouse morulae did not have the same effect as the mucin coat.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Embryo, Mammalian , Mucins/physiology , Refrigeration , Animals , Culture Techniques , Embryo, Mammalian/physiology , Female , Hypertonic Solutions , Isotonic Solutions , Male , Mice , Mice, Inbred ICR , Rabbits , Sucrose , Zona Pellucida/physiology
18.
Am J Gastroenterol ; 87(9): 1183-6, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1519577

ABSTRACT

A 60-yr-old female patient with rheumatoid arthritis presented with nonsteroidal anti-inflammatory drug (NSAID)-induced ileal ulcers which caused intestinal bleeding and multiple strictures. Results of investigations, including radiological, pathological, and bacteriological examinations, were not consistent with Crohn's disease or intestinal tuberculosis. Rather, the lesion was characteristic of "diaphragm disease" caused by NSAIDs. Discontinuance of NSAIDs in combination with administration of ornoprostil (prostaglandin E1-derivative), sucralfate, and sulfasalazine put an end to the intestinal bleeding. This is a rate case of a patient with multiple strictures of the small intestine caused by NSAIDs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Ileal Diseases/etiology , Ileal Diseases/pathology , Ileum/pathology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Rheumatoid/drug therapy , Female , Gastrointestinal Hemorrhage/chemically induced , Gastrointestinal Hemorrhage/complications , Humans , Middle Aged , Time Factors , Ulcer/chemically induced , Ulcer/complications , Ulcer/pathology
19.
Gan To Kagaku Ryoho ; 19(7): 946-53, 1992 Jul.
Article in Japanese | MEDLINE | ID: mdl-1626950

ABSTRACT

Mechanism of synergism and clinical results of methotrexate and 5-fluorouracil (MTX/5-FU) combination therapy for gastric cancer were studied. The response rate against poorly differentiated gastric cancers was 35% in this treatment. This treatment also showed a remarkable effect against cases with pleural and abdominal effusion caused by cancerous disseminations. A promising result was obtained by this treatment as neoadjuvant and postoperative chemotherapy against Borrmann type 4 gastric cancer. A greater dependence on the de novo pathway of pyrimidine synthesis against poorly differentiated gastric carcinoma, which was estimated by the fact that the thymidylate synthetase/thymidine kinase ratio was significantly higher in poorly differentiated gastric cancer than in well differentiated cancer, may potentiate therapeutic results of this treatment.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Cell Division/drug effects , Chemotherapy, Adjuvant , Drug Administration Schedule , Drug Synergism , Female , Fluorouracil/administration & dosage , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Survival Rate , Time Factors , Tumor Cells, Cultured/drug effects
20.
Surg Oncol ; 1(3): 215-21, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1341254

ABSTRACT

In a previous clinical study, sequential methotrexate and 5-fluorouracil has shown improved efficacy for treating advanced gastric cancer of the poorly differentiated type. In this study, we investigated whether difference in the levels of thymidylate synthetase (TS) and thymidine kinase (TK) activities in gastric cancer tissue account for selectivity of the treatment. Activity of TS was higher in 19 cases of the poorly differentiated type than in 16 cases of the well differentiated type (P < 0.02), whereas TK activity was lower in the poorly differentiated type than in the well differentiated type (P < 0.01). Thus, the TS/TK ratio was significantly higher in poorly differentiated gastric cancers than in well differentiated cancers (P < 0.001). These results suggest that a greater dependence upon the de novo pathway of pyrimidine synthesis in poorly differentiated gastric carcinomas may enhance the efficacy of sequential methotrexate and 5-fluorouracil treatment.


Subject(s)
Adenocarcinoma/enzymology , Stomach Neoplasms/enzymology , Thymidine Kinase/metabolism , Thymidylate Synthase/metabolism , Adenocarcinoma/drug therapy , Adenocarcinoma/epidemiology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Fluorouracil/administration & dosage , Humans , Linear Models , Male , Methotrexate/administration & dosage , Stomach/drug effects , Stomach/enzymology , Stomach Neoplasms/drug therapy , Stomach Neoplasms/epidemiology , Thymidine Kinase/analysis , Thymidine Kinase/drug effects , Thymidylate Synthase/analysis , Thymidylate Synthase/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...